Funder
National Natural Science Foundation of China
the Natural Science Foundation of Jiangsu Province
Soochow University College Students Innovation and Entrepreneurship Fund
Publisher
Springer Science and Business Media LLC
Subject
Cell Biology,Cellular and Molecular Neuroscience,Pharmacology,Molecular Biology,Molecular Medicine
Reference69 articles.
1. Lambert JM, Chari RV (2014) Ado-trastuzumab Emtansine (T-DM1): an antibody–drug conjugate (ADC) for HER2-positive breast cancer. ACS Publications
2. Pondé N, Aftimos P, Piccart M (2019) Antibody-drug conjugates in breast cancer: a comprehensive review. Curr Treat Options Oncol 20(5):37
3. Beck A, Goetsch L, Dumontet C, Corvaïa N (2017) Strategies and challenges for the next generation of antibody-drug conjugates. Nat Rev Drug Discov 16(5):315–337
4. Donaghy H (2016) Effects of antibody, drug and linker on the preclinical and clinical toxicities of antibody-drug conjugates. MAbs 8(4):659–671
5. Jain N, Smith SW, Ghone S, Tomczuk B (2015) Current ADC linker chemistry. Pharm Res 32(11):3526–3540